|

ABSK-011 Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • RenJi Hospital1
  • Abbisko Therapeutics Co, Ltd1

Indications

  • Liver Cancer2
  • Cancer2
  • Liver Disease1
  • Advanced Liver Cancer1
  • HCC - Hepatocellular Carcinoma1

Other1 trial

FGF19 Overexpression Combination Unified Study in HCC-19
Phase 2

Phoenix, Arizona1 trial

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor

Mayo Clinic

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.